Coronavirus Disease 2019 (COVID-19) : A Haematologist's Perspective

© 2020 S. Karger AG, Basel..

Coronavirus disease 2019 (COVID-19) is affecting millions of patients worldwide. It is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which belongs to the family Coronaviridae, with 80% genomic similarities to SARS-CoV. Lymphopenia was commonly seen in infected patients and has a correlation to disease severity. Thrombocytopenia, coagulation abnormalities, and disseminated intravascular coagulation were observed in COVID-19 patients, especially those with critical illness and non-survivors. This pandemic has caused disruption in communities and hospital services, as well as straining blood product supply, affecting chemotherapy treatment and haematopoietic stem cell transplantation schedule. In this article, we review the haematological manifestations of the disease and its implication on the management of patients with haematological disorders.

Errataetall:

CommentIn: Acta Haematol. 2021;144(1):8-9. - PMID 33032279

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:144

Enthalten in:

Acta haematologica - 144(2021), 1 vom: 03., Seite 10-23

Sprache:

Englisch

Beteiligte Personen:

Cheung, Carmen Ka Man [VerfasserIn]
Law, Man Fai [VerfasserIn]
Lui, Grace Chung Yan [VerfasserIn]
Wong, Sunny Hei [VerfasserIn]
Wong, Raymond Siu Ming [VerfasserIn]

Links:

Volltext

Themen:

COVID-19
Coagulation
Journal Article
Lymphopenia
Review
SARS-CoV-2

Anmerkungen:

Date Completed 01.02.2021

Date Revised 12.11.2023

published: Print-Electronic

CommentIn: Acta Haematol. 2021;144(1):8-9. - PMID 33032279

Citation Status MEDLINE

doi:

10.1159/000510178

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM312977115